The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 430.00
Bid: 420.00
Ask: 425.00
Change: -12.00 (-2.71%)
Spread: 5.00 (1.19%)
Open: 443.50
High: 443.50
Low: 421.00
Prev. Close: 442.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EBA European-wide stress test 2023

28 Jul 2023 17:51

RNS Number : 6301H
AIB Group PLC
28 July 2023
 

28 July 2023

 

AIB Group plc - European Banking Authority (EBA) European-wide stress test 2023

 

AIB notes the announcements made today by the EBA on the EU-wide stress test.

 

CFO comment on EBA EU-wide stress test

 

"Our result of 9.95% fully loaded CET1 in the EBA's hypothetical adverse scenario demonstrates our high capital base and capital resilience in the face of one of the most severe EBA adverse scenarios to date. Capital depletion of 6.3% marks an improvement on the 2021 exercise, despite this test being more severe.  AIB continues to be very well-capitalised with a CET1 ratio of 15.7% at H1 2023 which remains substantially in excess of regulatory requirements."

-Donal Galvin, CFO

 

Results of EBA EU-wide stress test

 

AIB Group plc ("AIB") was subject to the 2023 EUwide stress test conducted by the European Banking Authority (EBA), in cooperation with the Central Bank of Ireland (CBI), the European Central Bank (ECB), the European Commission (EC) and the European Systemic Risk Board (ESRB).

 

AIB's capital ratios and EBA stress test results are outlined below:

 

AIB CET 1 capital ratios

Dec 2022

CET 1 - Transitional

17.90%

CET 1 - Fully loaded

16.27%

 

 

EBA 2023 stress test results

Dec 2025

(Adverse scenario)

CET 1(1)

9.95%

 

 

The 2023 EU-wide stress test does not contain a pass-fail threshold and instead is designed to assist competent authorities in assessing AIB's ability to meet applicable prudential requirements under stressed scenarios.

 

The adverse stress test scenario was set by the ECB/ESRB and covers a three-year time horizon (2023-2025).

The stress test was carried out applying a static balance sheet assumption as of December 2022, and therefore does not take into account future business strategies and management actions. It is not a forecast of AIB's profits.

 

No capital action is envisaged for AIB as a result of the EBA stress test results.

 

 

The 2023 EBA stress test adverse scenario resulted in capital depletion of 6.3% on a fully loaded basis and is lower than the 2021 EBA stress test adverse scenario (capital depletion 6.8%), reflecting the improved risk profile of the Group. CET1 in the adverse scenario of 9.95% is well above the total SREP capital requirement (TSCR) of 6.05%(2).

 

AIB Group plc published its half-yearly financial results this morning, further information is available on our website.

-ENDS-

Further information:

· The severe nature of the adverse scenario reflects the EBA's deliberate choice and purpose of the stress test exercise, which is to assess the resilience of the European banking system to a hypothetical severely deteriorated macro-environment

· The EBA's 2023 adverse scenario is the most severe to date in terms of GDP decline. The scenario also includes a significant shock to Irish unemployment which is assumed to increase from a low starting position of 4.7% at Dec 2022 to a peak of 12.4%. For further scenario information, please refer to the EBA website here

· Due to the methodology, net interest income (NII) was capped at 2022 levels such that the increasing interest rate environment was not incorporated into the assessment.

· AIB's stress test results are heavily influenced by past experience and historical credit losses; they do not fully capture the significant improvements in risk management and credit underwriting since the global financial crisis (GFC)

 

To view the results including disclosure templates published by EBA for AIB please http://www.rns-pdf.londonstockexchange.com/rns/6301H_1-2023-7-28.pdf

 

 

[1]  Note that both the transitional and fully loaded CET1 ratios are the same by the end of the stress test period as all transitional adjustments are fully phased out.

(2) TSCR is the sum of Pillar 1 (4.5%) and Pillar 2 requirement (1.55%) and excludes combined buffer requirements

 

For further information, please contact:

 

Niamh Hore / Siobhain Walsh

Kathleen Barrington/Paddy McDonnell

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-86-3135647 / +353-87-3956864

Tel: +353-87-408-8323 / +353-87-7390743

email: niamh.a.hore@aib.ie

siobhain.m.walsh@aib.ie

email:  kathleen.m.barrington@aib.ie

 ………..paddy.x.mcdonnell@aib.ie

 

 

Forward Looking Statements

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in the Principal risks on pages 23 to 25 in the Annual Financial Report 2022 and updated on page 33 of the Half-Yearly Financial Report 2023. In addition to matters relating to the Group's business, future performance will be impacted by the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, the impact of higher inflation on customer sentiment and by Irish, UK and wider European and global economic and financial market considerations. Future performance will further be impacted by the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions and any enduring effects of the COVID-19 pandemic. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 23 to 25 of the Annual Financial Report 2022 is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward looking statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZNVRKGFZM
Date   Source Headline
14th Oct 20215:11 pmRNSAIB - sale of non-performing loan portfolio
5th Oct 202110:00 amRNSAIB confirms date for Q3 2021 Trading Update
14th Sep 202111:00 amRNSAppointment of Directors
1st Sep 20217:00 amRNSAIB - acquisition of Goodbody completion
6th Aug 202112:30 pmRNSNotification of Transaction by PDMR and PCA
4th Aug 20217:00 amRNSAIB - Half-Yearly Financial Results 2021
30th Jul 20215:28 pmRNSAIB Group plc – EBA European-Wide Stress Test 2021
30th Jun 20213:00 pmRNSAIB Group confirms date for HY21 Financial Results
28th Jun 20217:02 amRNSAIB acquisition of EUR4.2bn Ulster Bank loans
25th Jun 202111:00 amRNSNotification of Major Holdings
23rd Jun 20215:36 pmRNSAIB forms JV with Great-West Lifeco
18th Jun 202110:00 amRNSAppointment of Director
28th May 202111:00 amRNSAppointment of Executive Director
11th May 202112:00 pmRNSStabilisation Notice
10th May 20218:26 amRNSStabilisation Notice
6th May 20213:30 pmRNSResults of AGM 2021
6th May 20217:00 amRNSAIB Group plc Q1 2021 Trading Update
20th Apr 20211:04 pmRNSAIB confirms date for Q1 2021 Trading Update
1st Apr 20213:00 pmRNSNotice of Annual General Meeting 2021
29th Mar 202112:00 pmRNSChange in Director Details
16th Mar 20214:45 pmRNSChange in Director Details
15th Mar 20213:00 pmRNSAppointment of Director
11th Mar 202111:00 amRNSUpdate on Migration from CREST to Euroclear Bank
10th Mar 20219:30 amRNSNotification of Transaction by PDMR
8th Mar 202110:20 amRNSNotification of Transaction by PDMR
5th Mar 20217:00 amRNSAIB Group plc - 2020 Annual Financial Results
2nd Mar 20212:00 pmRNSAIB Group plc - Acquisition of Goodbody
19th Feb 20217:12 amRNSAIB – Sale of non-performing loan portfolio
19th Feb 20217:10 amRNSAIB-potential acq Ulster Bk's Corp & Comm loan bk
5th Feb 202112:00 pmRNSResults of Extraordinary General Meeting
22nd Jan 202110:00 amRNSAppointment of Director
14th Jan 202110:00 amRNSNotice of Results - AIB to publish on 5 March 2021
11th Jan 20213:00 pmRNSNotice of Extraordinary General Meeting
30th Dec 20207:00 amRNSAIB Group plc - Currency Change on LSE
22nd Dec 202012:30 pmRNSForm 8.3 - Studio Retail Group plc
8th Dec 20202:52 pmRNSNotification of Major Holdings
2nd Dec 20207:00 amRNSAIB Group plc Medium-Term Targets
5th Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSTrading Statement
7th Oct 202012:39 pmRNSAIB announces date for Q3 2020 Trading Update
2nd Oct 20201:29 pmRNSStabilisation Notice
23rd Sep 202010:28 amRNSStabilisation Notice
4th Sep 20205:53 pmRNSAIB Group plc H1 2020 Pillar 3 Report
13th Aug 202010:00 amRNSNotification of Major Holdings
6th Aug 20207:00 amRNSAIB Half-Year Financial Results 2020
30th Jul 20206:15 pmRNSDirectorate Change
3rd Jul 20201:01 pmRNSAIB confirms 6 Aug for H1 2020 Financial Results
17th Jun 20208:47 amRNSStabilisation Notice
16th Jun 20208:18 amRNSStabilisation Notice
16th Jun 20207:54 amRNSTender Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.